Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ornithine Aspartate Injection

Approval Number

国药准字H20213366

Company扬子江药业集团广州海瑞药业有限公司

Registration Date

May 19, 2021

Drug Information

Generic Name

门冬氨酸鸟氨酸注射液

Dosage Form

注射剂

Strength

10ml:5g

Drug Type

化学药品

Registration Date

May 19, 2021

Company Information

Applicant Company

Company Name扬子江药业集团广州海瑞药业有限公司

Company Address

广州高新技术产业开发区广州科学城香山路31号

Manufacturing Company

Company Name扬子江药业集团广州海瑞药业有限公司

Company Address

广州高新技术产业开发区广州科学城香山路31号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy